Novavax, Inc. logo Novavax, Inc. Net Promoter Score 2018 Benchmarks

Estimated Net Promoter Score is

7

Novavax, Inc. is a clinical-stage vaccine company headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is a public company that trades under the symbol "NVAX".

In June 2013, Novavax acquired the Matrix-MTM adjuvant platform with the purchase of Swedish company Isconova AB and renamed it Novavax AB.

In 2015 the company received an $89 million grant from the Bill & Melinda Gates Foundation to support the development of a vaccine against human respiratory syncytial virus for infants via maternal immunization.

In March 2015 the company completed a Phase I trial for its Ebola vaccine candidate.

In September 2016 the company announced that a Phase III trial of its RSV vaccine had failed to meet its endpoints, which caused its share price to fall from $8.34 to $1.40 and led the company to lay off 30% of its employees.

As of November 2016 its RSV F vaccine candidate was in three clinical trials.

Quick facts about Novavax, Inc.

Traded as NASDAQ: NVAX S&P 500 Component
Headquarters Gaithersburg, Maryland, U.S.
Founded 1987; 30 years ago (1987)
Website www.novavax.com
Industry Biotechnology

Net Promoter Score for Top Brands compared with Novavax, Inc.

NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.

It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.

The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.

Learn more about NPS

Yes, it is.

Net Promoter Score is a number from -100 from 100.

Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.

The industry average for Health Care / Biotechnology: Biological Products (No Diagnostic Substances) is 0.



Browse NPS benchmarks

Customer.guru survey demo

important
How to understand the NPS benchmarks

The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.

Consider an example: If Novavax, Inc. sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.

On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.

Therefore, comparing the NPS score of Novavax, Inc. with your own without any further context is not that useful.

What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.

Learn more

Track Segmented Customer Satisfaction with Customer.guru

How are your customers satisfied depending on:

  • what products they purchased
  • when they placed their order
  • what number of orders they made?

    Sign up for free setup takes just 5 minutes

Other companies with Net Promoter Score similar to Novavax, Inc.

We have estimated the Net Promoter Score of Novavax, Inc. based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.

Do you think this information is incorrect? Report incorrect information. Do you have more accurate data? Submit NPS score.